PlainPharmaWatch

CMS Open Payments · Program Year 2024

BioWound Solutions, Inc.

BioWound Solutions, Inc. reported $24,070.60 across General Payments, Research, and Ownership to 124 physicians and teaching hospitals across 124 transactions.

$24.1K
All-tracks total
124
Transactions
124
Recipients
#1501
of 1,925 companies

BioWound Solutions, Inc. reported $24,070.60 across all CMS Open Payments tracks (General + Research + Ownership) to 124 physicians and teaching hospitals in Program Year 2024 - ranking #1501 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $24,070.60, averaging $194.12 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer biowound-solutions-inc BioWound Solutions, Inc.

$24.1K · #1501/1,925 · 0.0% industry · PY2024

  • TOT $24.1K
  • RANK #1501
  • SHARE 0.0%
  • TXN 124
  • RCP 124
  • CAT 2
  • GEN $24.1K
  • TOP1 34.7%
  • PY 2024

Nearest volume peer: PFM Medical, Inc. ($24.0K)

Helsinn Therapeutics (U.S.),…$24.3KBioWound Solutions, Inc. (th…$24.1KPFM Medical, Inc.$24.0KGoode Surgical Inc$24.0KKinamed, Inc.$23.8K
All-tracks payment totals near BioWound Solutions, Inc. (CMS Open Payments PY2024)

BioWound Solutions, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for BioWound Solutions, Inc.

In Program Year 2024, BioWound Solutions, Inc. reported $24,070.60 in payments to 124 physicians and teaching hospitals across 124 individual transactions, an average of $194.12 per transaction and $194.12 per recipient. That total places BioWound Solutions, Inc. at rank #1501 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $19.3K across 7 transactions, 80.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads BioWound Solutions, Inc.'s 2-category general-payment breakdown at $19.3K, 80.4% of the reported total.

How BioWound Solutions, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$19.3K2. Food and Beverage$4.7K
Payment Type Amount Transactions
Consulting Fee $19.3K 7
Food and Beverage $4.7K 117

Recipient Concentration in General Payments

The five largest recipient relationships account for $19,676.42 (81.7%) of $24,070.60 in this company's General Payments records across 98 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for BioWound Solutions, Inc.

The five named recipients with the highest reported General Payments from this company

Michael J Bauer$8.3KSharon Y Hook$6.0KWilliam Tettelbach$5.0KHsien Sing Sam Hsieh$169.01Kelly D Mcfee$164.41
  1. 1

    Michael J Bauer

    $8,343.00 across 4 reported transactions

  2. 2

    Sharon Y Hook

    $6,000.00 across 2 reported transactions

  3. 3

    William Tettelbach

    $5,000.00 across 1 reported transactions

  4. 4

    Hsien Sing Sam Hsieh

    $169.01 across 1 reported transactions

  5. 5

    Kelly D Mcfee

    $164.41 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as BioWound Solutions, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about BioWound Solutions, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with BioWound Solutions, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download BioWound Solutions, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.